All entries for: Neurological

November 6, 2025

LB PHARMACEUTICALS INC

Neutral Outlook

New York, New York,
1-50 employees

There have been judicial, executive and congressional challenges and amendments to certain aspects of the ACA. For example, the Inflation Reduction Act of 2022, or IRA, among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in ACA marketplaces through plan year 2025.

Disease Area: Neurological
Drug Type: Small Molecule
November 5, 2025

Dyne Therapeutics, Inc

Neutral Outlook

Waltham, Massachusetts,
501-1,000 employees

On August 16, 2022, the Inflation Reduction Act, or the IRA, was signed into law by President Biden. The new legislation has implications for Medicare Part D, which is a program available to individuals who are entitled to Medicare Part A or enrolled in Medicare Part B to give them the option of paying a monthly premium for outpatient prescription drug coverage.

Disease Area: Neurological
Drug Type: Biologic, Small Molecule
Scroll to Top